Novel Biomarkers for Pulmonary Drug Development

The UNC CF Center has developed a number of novel biomarkers for measuring the pharmacodynamic and therapeutic effects of inhaled therapeutic agents in sputum. Much effort has been focused on the measurement of the proper vs. improper hydration of mucus in airway diseases. Consequently, the UNC CF Center has a spectrum of technologies designed to measure these parameters in induced or expectorated sputum, including measures of absolute mucin concentrations, mucin/mucus osmotic pressure/modulus, and measures of mucus adhesion (see Figure 21). In parallel, the UNC CF Center has the capacity to measure a large number of classical biomarkers in sputum through our Sputum Core, including measures of cell counts, cytokines, and growth factors.

 


Inquiries

Questions? If you are interested in learning more about how the UNC CF Center can help further your research, or are interested in collaborating with us, please contact our CF Center Director, Dr. Richard Boucher:

7011 Thurston-Bowles Bldg.
The University of North Carolina at Chapel Hill
Campus Box #7248
Phone: (919) 966-1077
Fax: (919) 966-5178
Email: richard_boucher@med.unc.edu

[top]